Basics Neuronetics, Inc. Common Stock IPO Date: June 25, 2018 Sector: Healthcare Industry: Diagnostics and Research Market Cap: $213.58M Activated in VL: True Average Daily Range Avg Daily Range: $0.25 | 3.77% Avg Daily Range (30 D): $0.13 | 3.41% Avg Daily Range (90 D): $0.12 | 3.02% Institutional Daily Volume Avg Daily Volume: .33M Avg Daily Volume (30 D): 1.35M Avg Daily Volume (90 D): .94M Trade Size Avg Trade Size (Sh.): 145 Avg Trade Size (Sh.) (30 D): 154 Avg Trade Size (Sh.) (90 D): 133 Institutional Trades Total Inst.Trades: 153 Avg Inst. Trade: $1.9M Avg Inst. Trade (30 D): $.8M Avg Inst. Trade (90 D): $2.25M Avg Inst. Trade Volume: .18M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $4.65M Avg Closing Trade (30 D): $10.91M Avg Closing Trade (90 D): $6.22M Avg Closing Volume: 499.32K     News Dec 10, 2024 @ 3:00 PM Neuronetics and Greenbrook TMS Announce Closing of... Source: N/A Jul 2, 2024 @ 2:40 PM Neuronetics (STIM) Expands NeuroStar Portfolio Wit... Source: Zacks Equity Research Jul 1, 2024 @ 12:02 PM NeuroStar® Launches Better Me Provider Program ... Source: Neuronetics Jun 13, 2024 @ 12:31 PM NeuroStar Showcases Cutting-Edge Research at Clini... Source: Neuronetics May 23, 2024 @ 12:30 PM Neuronetics to Present at the William Blair 44th A... Source: Neuronetics Financials   TTM Q2 2025 Q1 2025 Basic EPS $-1.14 $-.15 $-.21 Diluted EPS $-1.14 $-.15 $-.21 Revenue $ 111.11M $ 38.11M $ 31.98M Gross Profit $ 62.39M $ 17.76M $ 15.74M Net Income / Loss $ -48.55M $ -9.84M $ -12.69M Operating Income / Loss $ -38.27M $ -8.06M $ -11.01M Cost of Revenue $ 48.72M $ 20.35M $ 16.24M Net Cash Flow $ -32.99M $ -3.76M $ 1.77M PE Ratio